Unchanged density of 5-HT1A autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine

Neuroscience

Volumn 151, Issue 3, 2008, Pages 692-700

  Riad, M ^a   Rbah, L ^b,c   Verdurand, M ^b,c   Aznavour, N ^c   Zimmer, L ^b,c   Descarries, L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LYON 1   (France)

^c CERMEP IMAGERIE DU VIVANT   (France)

Author keywords

5 HT1A autoreceptors; 18F MPPF; desensitization; fluoxetine; immunogold; internalization

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4,2 (METHOXYPHENYL) 1 [2 (N 2 PYRIDINYL) 4 FLUOROBENZAMIDO]ETHYLPIPERAZINE F 18; FLUOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN; RADIOLIGAND; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL MEMBRANE; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DESENSITIZATION; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CELL MEMBRANE; DRUG INTERACTIONS; FLUOXETINE; HIPPOCAMPUS; MALE; MICROSCOPY, IMMUNOELECTRON; MODELS, NEUROLOGICAL; NEURONS; PROTEIN BINDING; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN UPTAKE INHIBITORS;

EID: 38949123327     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.11.024     Document Type: Article

References (64)

1. 1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10 (2004) 575-593
2. 1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn Schmiedebergs Arch Pharmacol 353 (1996) 630-640
3. 1A antagonists. Trends Neurosci 19 (1996) 378-383
4. 1A receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage 33 (2006) 834-842
5. 1A receptors in animal and human brain. Neuropharmacology 52 (2007) 695-707
6. 3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol 178 (1990) 179-187
7. Bel N., and Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15 (1993) 243-245
8. Benmansour S., Cecchi M., Morilak D.A., Gerhardt G.A., Javors M.A., Gould G.G., and Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19 (1999) 10494-10501
9. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., and Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22 (2002) 6766-6772
10. Blier P., and de Montigny C. Current advances in the treatment of depression. Trends Pharmacol Sci 15 (1994) 220-226
11. Blier P., Lista A., and de Montigny C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus. II. Effects of pertussis and cholera toxins. J Pharmacol Exp Ther 265 (1993) 16-23
12. 1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. J Neurochem 72 (1999) 262-272
13. Claing A., Laporte S.A., Caron M.G., and Lefkowitz R.J. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog Neurobiol 66 (2002) 61-79
14. Cosford R.J.S., Vinson A.P., Kukoyi S., and Justice J.B. Quantitative microdialysis of serotonin and norepinephrine: Pharmacological influences on in vivo extraction fraction. J Neurosci Methods 68 (1996) 39-47
15. Cremers T.I., Spoelstra E.N., de Boer P., Bosker F.J., Mork A., den Boer J.A., Westerink B.H., and Wikstrom H.V. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. Eur J Pharmacol 397 (2000) 351-357
16. Czachura J.F., and Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol 362 (2000) 266-275
17. Dawson L.A., Nguyen H.Q., Smith D.I., and Schechter L.E. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study. Br J Pharmacol 130 (2000) 797-804
18. Dawson L.A., Nguyen H.Q., Smith D.L., and Schechter L.E. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16 (2002) 145-152
19. 1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 118 (1990) 189-192
20. 1A receptors in rat brain. Neuropharmacology 44 (2003) 93-101
21. 1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12 (2000) 2299-2310
22. Fanelli R.J., and McMonagle-Strucko K. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse 12 (1992) 75-81
23. Fuller R.W. Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. Prog Drug Res 45 (1995) 167-204
24. 1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10 (1996) 16-27
25. 1A receptors. J Neurosci 18 (1998) 10150-10156
26. 1A receptors in the rat brain. Neuropharmacology 47 (2004) 515-526
27. 1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26 (2002) 565-573
28. Hervás I., and Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol 358 (1998) 9-18
29. 1A autoreceptors by a low chronic fluoxetine dose: Effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 24 (2001) 11-20
30. Invernizzi R., Bramante M., and Samanin R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res 696 (1995) 62-66
31. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol Biochem Behav 54 (1996) 143-147
32. Justice J.B. Quantitative microdialysis of neurotransmitters. J Neurosci Methods 48 (1993) 261-276
33. Kim S.W., Park S.Y., and Hwang O. Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Mol Pharmacol 61 (2002) 778-785
34. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274 (1995) 866-876
35. La Cour C.M., El Mestikawy S., Hanoun N., Hamon M., and Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70 (2006) 1013-1021
36. 18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 25 (1998) 343-350
37. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., and Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23 (2003) 8788-8799
38. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 141-148
39. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
40. 1A agonist. J Pharmacol Exp Ther 279 (1996) 1035-1042
41. 1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci 20 (2000) 7888-7895
42. Malagié I., Deslandes A., and Gardier A.M. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403 (2000) 55-65
43. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21 (1999) 99S-105S
44. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23 (1997) 145-195
45. Moret C., and Briley M. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295 (1996) 189-197
46. Naughton M., Mulrooney J.B., and Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 15 (2000) 397-415
47. 1B autoreceptors: regional differences and effects of WAY-100635. Eur J Pharmacol 486 (2004) 25-30
48. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., and Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59 (2006) 106-113
49. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates. Fourth edition. Sydney: Academic Press.
50. Pejchal T., Foley M.A., Kosofsky B.E., and Waeber C. Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol 135 (2002) 1115-1122
51. Piñeyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51 (1999) 533-591
52. 1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther 288 (1999) 98-106
53. 1A receptors with specific antibodies. Neurochem Int 19 (1991) 413-423
54. Riad M., Watkins K.C., Doucet E., Hamon M., and Descarries L. Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 21 (2001) 8378-8386
55. 18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24 (2004) 5420-5426
56. Rutter J.J., Gundlah C., and Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171 (1994) 183-186
57. 1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment. Br J Pharmacol 126 (1999) 1777-1784
58. 35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42 (2002) 1031-1038
59. 1A receptor mRNA in discrete regions of the rat brain. Psychiatry Clin Neurosci 50 (1996) 141-146
60. Shishkina G.T., Kalinina T.S., and Dygalo N.N. Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effects. Neuroscience 150 (2007) 404-412
61. 18F]MPPF binding in the dorsal raphe nucleus after a single oral dose of fluoxetine: a PET study in healthy volunteers. Biol Psychiatry (2007), doi: 10.1016/j.biopsych.2007.11.016.
62. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18 (1998) 7394-7401
63. Welner S.A., de Montigny C., Desroches J., Desjardins P., and Suranyi-Cadotte B.E. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4 (1989) 347-352
64. 1A autoreceptor internalization. Neuroimage 22 (2004) 1421-1426